We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

PerkinElmer Completes Acquisition of Caliper Life Sciences

By LabMedica International staff writers
Posted on 08 Nov 2011
PerkinElmer, Inc. (Waltham, MA, USA) announced the completion of the acquisition of Caliper Life Sciences, Inc. (Hopkinton, MA, USA), a leader in imaging and detection solutions for life sciences research, diagnostics, and environmental markets. PerkinElmer had announced its intent to acquire Caliper for approximately USD 600 million in cash, in September 2011.

The combined technology platforms of the companies will expand PerkinElmer's portfolio of solutions and services to provide broader offerings for molecular, cellular, animal and tissue imaging to enable translational medicine research, as well as add a microfluidics platform for genomics and proteomics applications and high-value sample preparation technologies for key scientific workflow areas such as Next Generation DNA Sequencing, with comprehensive solutions and services for identification of therapeutic response, biotherapeutics development and biologics QA/QC.

Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, "The integration of Caliper into our organization will further strengthen PerkinElmer's position in personalized medicine. The acquisition will enhance our ability to provide customers with the complementary technologies, services and knowledge they need to drive innovation from in vivo to in vitro imaging, and provide expanded offerings across our biomedical, diagnostics, environmental and food safety end-markets."

Friel added, "I am also very pleased to welcome Kevin Hrusovsky, who was Caliper's CEO, to PerkinElmer. Kevin will lead a newly combined USD 500 million business, which integrates the former Caliper organization with PerkinElmer's existing research business."

PerkinElmer designs and manufactures technology solutions for health and environmental concerns. The company reported revenues of approximately USD 1.7 billion in 2010, and has about 7,000 employees serving customers in more than 150 countries.

Related Links:
PerkinElmer
Caliper Life Sciences



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Automated Blood Typing System
IH-500 NEXT
New
Incubator
HettCube 120
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries